Drug treatment of diseases characterized by abnormal movements.
作者信息
Marsden C D
出版信息
Proc R Soc Med. 1973 Sep;66(9):871-3. doi: 10.1177/003591577306600920.
Abstract
摘要
相似文献
1
Drug treatment of diseases characterized by abnormal movements.以异常运动为特征的疾病的药物治疗。
Proc R Soc Med. 1973 Sep;66(9):871-3. doi: 10.1177/003591577306600920.
2
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.泰必利嗪治疗运动障碍：文献综述。
Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28.
3
[Use of haloperidol in the treatment of extrapyramidal compulsive movement].氟哌啶醇在锥体外系强迫运动治疗中的应用
Nervenarzt. 1970 Nov;41(11):567-9.
4
[Haloperidol, reserpine, l-dopa and amantidine in the treatment of Huntington chorea (author's transl)].氟哌啶醇、利血平、左旋多巴和金刚烷胺治疗亨廷顿舞蹈病（作者译）
Riv Patol Nerv Ment. 1976 Jan-Feb;96(1):54-62.
5
How best to address these common movement disorders.如何最好地应对这些常见的运动障碍。
J Fam Pract. 2011 Dec;60(12):721-5.
6
[Therapeutical approach to involuntary movements (author's transl)].
Sem Hop. 1979;55(5-6):262-4.
7
Involuntary movement disorders.运动障碍性疾病
Neurol Clin. 1984 Feb;2(1):71-89.
8
Tetrabenazine in the treatment of hyperkinetic movement disorders.丁苯那嗪治疗运动亢进性运动障碍
Expert Rev Neurother. 2006 Jan;6(1):7-17. doi: 10.1586/14737175.6.1.7.
9
Tetrabenazine in the treatment of hyperkinetic movement disorders.丁苯那嗪治疗运动亢进性运动障碍
Adv Neurol. 1983;37:277-89.
10
[Cholinergizing treatment in hyperkinesis].
Neurol Neurochir Pol. 1978 May-Jun;12(3):257-61.
引用本文的文献
1
Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.探索基于小分子的治疗方法在靶向三核苷酸重复序列疾病中的潜力。
Mol Neurobiol. 2020 Jan;57(1):566-584. doi: 10.1007/s12035-019-01724-4. Epub 2019 Aug 9.
2
An Update on the Treatment of Chorea.舞蹈症治疗的最新进展
Curr Treat Options Neurol. 2018 Sep 25;20(10):44. doi: 10.1007/s11940-018-0529-y.
3
Tourette syndrome research highlights from 2017.2017年抽动秽语综合征研究亮点
F1000Res. 2018 Jul 23;7:1122. doi: 10.12688/f1000research.15558.1. eCollection 2018.
4
Huntington's disease: the coming of age.亨廷顿舞蹈症：走向成熟
J Genet. 2018 Jul;97(3):649-664.
5
How Many Dystonias? Clinical Evidence.有多少种肌张力障碍？临床证据。
Front Neurol. 2017 Feb 3;8:18. doi: 10.3389/fneur.2017.00018. eCollection 2017.
6
Substance of abuse and movement disorders: complex interactions and comorbidities.滥用物质与运动障碍：复杂的相互作用和共病现象。
Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243.
7
Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.丁苯那嗪（Nitoman）治疗慢性自发性口腔运动障碍。一项视频和肌电图控制的研究。
Eur Arch Psychiatry Neurol Sci. 1984;234(3):172-4. doi: 10.1007/BF00461557.
本文引用的文献
1
[Treatment of Huntington's chorea with chlorpromazine (largactil) and thioridazine (melleril)].[用氯丙嗪（利血平）和硫利达嗪（美立廉）治疗亨廷顿舞蹈病]
Rev Otoneuroophtalmol. 1959;31:498-501.
2
Reserpine in Huntington's chorea.利血平治疗亨廷顿舞蹈病。
Neurology. 1960 Jan;10:38-42. doi: 10.1212/wnl.10.1.38.
3
Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine.氯丙嗪作用后大鼠脑内从酪氨酸-C14加速合成多巴胺-C14。
Life Sci. 1967 Nov 1;6(21):2307-12. doi: 10.1016/0024-3205(67)90040-9.
4
Peripheral beta-adrenergic receptors concerned with tremor.与震颤相关的外周β-肾上腺素能受体。
Clin Sci. 1967 Aug;33(1):53-65.
5
Modification of sympathetic function. Pharmacological depletion of catecholamine stores.交感神经功能的改变。儿茶酚胺储备的药理学耗竭。
Pharmacol Rev. 1966 Mar;18(1):541-9.
6
Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa.扭转性肌张力障碍和痉挛性斜颈——左旋多巴治疗结果
Neurology. 1970 Nov;20(11):107-13. doi: 10.1212/wnl.20.11_part_2.107.
7
Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol.
Br J Psychiatry. 1967 Apr;113(497):375-81. doi: 10.1192/bjp.113.497.375.
8
Dopamine (3-hydroxytyramine) and brain function.多巴胺（3-羟酪胺）与脑功能。
Pharmacol Rev. 1966 Jun;18(2):925-64.
9
10
Similarities between neurologic effects of L-dopa and of apomorphine.左旋多巴与阿扑吗啡对神经系统作用的相似性。
N Engl J Med. 1970 Jan 1;282(1):31-3. doi: 10.1056/NEJM197001012820107.
Zotero 插件